Long non-coding RNA PCAT1 promotes cell migration and invasion in human laryngeal cancer by sponging miR-210-3p

被引:5
作者
Hu, Weiqun [1 ]
Dong, Na [2 ]
Huang, Jinqiao [1 ]
Ye, Ben [3 ]
机构
[1] Putian Univ, Dept Otolaryngol, Affiliated Hosp, Putian 351100, Peoples R China
[2] Weifang Yidu Cent Hosp, Dept Orthoped Spinal Trauma, Weifang 262500, Peoples R China
[3] Shandong First Med Univ, Shandong Prov Hosp, Dept Otorhinolaryngol, 324 Jingwu Rd, Jinan 250000, Shandong, Peoples R China
来源
JOURNAL OF BUON | 2019年 / 24卷 / 06期
关键词
Long non-coding RNA; PCAT1; laryngeal cancer; miR-210-3p; PROLIFERATION; CHEMOTHERAPY; METASTASIS; RESISTANCE; LINKS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Laryngeal cancer (LC) is one of the most ordinary head and neck cancers worldwide. In this study, the role of long non-coding RNA (lncRNA) PCAT1 in LC was explored. Methods: PCAT1 expression in 50 paired tissue samples from LC patients was monitored by real-time quantitative polymerase chain reaction (RT-qPCR). Afterwards, function assays were conducted to explore how PCATI participated in metastasis of LC in vitro and in vivo. Then, bio-information software and luciferase assay were utilized to predict the possible target microRNA (miR) of PCAT1 in LC. Results: PCAT1 was obviously upregulated in LC tissues compared with adjacent tissues. Knockdown of PCAT1 inhibited the ability of cell migration and invasion in LC. Moreover, knockdown of PCAT1 inhibited tumor formation in vivo. Furthermore, miR-210-3p was sponged by PCAT1 in LC cells. Conclusion: PCAT1 was first identified as a novel oncogene in LC and could promote LC cell migration and invasion by sponging miR-210-3p.
引用
收藏
页码:2429 / 2434
页数:6
相关论文
共 16 条
  • [1] Andreadis C, 2007, J BUON, V12, P341
  • [2] Dincer M, 2012, J BUON, V17, P337
  • [3] Li H, 2017, TUMOR BIOL, V39
  • [4] Down-regulation of miR-210-3p encourages chemotherapy resistance of renal cell carcinoma via modulating ABCC1
    Li, Songchao
    Yang, Jinjian
    Wang, Jun
    Gao, Wansheng
    Ding, Yafei
    Ding, Yinghui
    Jia, Zhankui
    [J]. CELL AND BIOSCIENCE, 2018, 8
  • [5] Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer
    Liu, Tong
    Zhang, Xin
    Gao, Shanyu
    Jing, Fangmiao
    Yang, Yongmei
    Du, Lutao
    Zheng, Guixi
    Li, Peilong
    Li, Chen
    Wang, Chuanxin
    [J]. ONCOTARGET, 2016, 7 (51) : 85551 - 85563
  • [6] Ma TT, 2018, EUR REV MED PHARMACO, V22, P1907, DOI 10.26355/eurrev_201804_14713
  • [7] The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc
    Prensner, John R.
    Chen, Wei
    Han, Sumin
    Iyer, Matthew K.
    Cao, Qi
    Kothari, Vishal
    Evans, Joseph R.
    Knudsen, Karen E.
    Paulsen, Michelle T.
    Ljungman, Mats
    Lawrence, Theodore S.
    Chinnaiyan, Arulm.
    Feng, Felix Y.
    [J]. NEOPLASIA, 2014, 16 (11): : 900 - 908
  • [8] Knockdown of long non-coding RNA prostate cancer-associated ncRNA transcript 1 inhibits multidrug resistance and c-Myc-dependent aggressiveness in colorectal cancer Caco-2 and HT-29 cells
    Qiao, Lei
    Liu, Xiangyu
    Tang, Yichao
    Zhao, Zheng
    Zhang, Jilong
    Liu, Huayan
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2018, 441 (1-2) : 99 - 108
  • [9] The long noncoding RNA PCAT-1 links the microRNA miR-215 to oncogene CRKL-mediated signaling in hepatocellular carcinoma
    Ren, Yanli
    Shang, Jinhua
    Li, Jinliang
    Liu, Wenjuan
    Zhang, Zhao
    Yuan, Jupeng
    Yang, Ming
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (43) : 17939 - 17949
  • [10] miR-30a-5p together with miR-210-3p as a promising biomarker for non-small cell lung cancer: A preliminary study
    Switlik, Weronika
    Karbownik, Michal Seweryn
    Suwalski, Michal
    Kozak, Jozef
    Szemraj, Janusz
    [J]. CANCER BIOMARKERS, 2018, 21 (02) : 479 - 488